3 Followers on Owler
OverviewCompetitorsFundingNews & Insights

Art Stent Competitors or Alternatives

Art Stent's top competitors include Amaranth Medical, Neotherix and Kuros Biosciences AG.

Unlock 2 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Art Stent's company profile

Machiel Van Der Leest

CEO

68/100
100 - 250
$8.5M
$5M - 25M
  • $8.5M
    $5M - 25M
  • 100 - 250
    $8.5M
  • $5M - 25M
  • 68/100
  • 100 - 250
  • $8.5M
  • $5M - 25M
View ProfileView
1
Art Stent's Competitor - Amaranth Medical logo

Kamal Ramzipoor

President & CEO

78/100
25 - 100
$27.5M
$5M - 25M
  • $27.5M
    $5M - 25M
  • 25 - 100
    $27.5M
  • $5M - 25M
  • 78/100
  • 25 - 100
  • $27.5M
  • $5M - 25M
View ProfileView
2
Art Stent's Competitor - Neotherix logo

Mike Raxworthy

CEO

70/100
1 - 25
- -
$100K - 5M
  • - -
    $100K - 5M
  • 1 - 25
    - -
  • $100K - 5M
  • 70/100
  • 1 - 25
  • - -
  • $100K - 5M
View ProfileView
3
Art Stent's Competitor - Kuros Biosciences AG logo

Joost De Bruijn

CEO

90/100
25 - 100
$25.3M
$100K - 5M
  • $25.3M
    $100K - 5M
  • 25 - 100
    $25.3M
  • $100K - 5M
  • 90/100
  • 25 - 100
  • $25.3M
  • $100K - 5M
View ProfileView
4
Art Stent's Competitor - Terumo Medical logo

CEO

- -
1,000 - 5,000
- -
$100M - 500M
  • - -
    $100M - 500M
  • 1,000 - 5,000
    - -
  • $100M - 500M
  • - -
  • 1,000 - 5,000
  • - -
  • $100M - 500M
View ProfileView
Art Stent's top 5 competitors are Amaranth Medical, Neotherix, Kuros Biosciences AG, Elixir and Terumo Medical. Together they have raised over 58.1M between their estimated 1.6K employees. Art Stent's revenue is the ranked 3rd among it's top 10 competitors. The top 10 competitors average 47M. Art Stent has 161 employees and is ranked 2nd among it's top 10 competitors. The top 10 competitors average 299.

Art Stent VS Amaranth Medical

Amaranth Medical is a top competitor of Art Stent. Amaranth Medical was founded in Mountain View, California} in 2005. Amaranth Medical competes in the Biotechnology industry. Compared to Art Stent, Amaranth Medical generates $2M more revenue.

Art Stent VS Neotherix

Neotherix is Art Stent's #2 competitor. Neotherix is headquartered in York, England, and was founded in 2007. Neotherix competes in the Health Care Services field. Neotherix generates 15% the revenue of Art Stent.

Looking for similar companies to Art Stent?

Similar Companies

Health Care Services companies in Paris

See 230 companies 
Health Care Equipment & Services companies in Paris

See 579 companies 
Health Care Services companies in Île-de-France

See 231 companies 
Companies in Paris with employees in 100-250 range

See 606 companies 
Health Care Equipment & Services companies in Île-de-France

See 655 companies 
Companies in Île-de-France with employees in 100-250 range

See 778 companies 
Health Care Services companies in France

See 1,009 companies 
Companies in France with employees in 100-250 range

See 1,596 companies 
Companies in Paris with revenue in $5.0-25M range

See 1,976 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Art Stent and Art Stent's Competitors

Today 7:03 PMStartTribune
Boston Scientific, which is growing in Minnesota, is buying California's Penumbra for $14.5 billion. CEO Mike Mahoney said the deal makes his company a...
January 15, 2026Drug Delivery Business
Kilkenny Live reports that Abbott (NYSE:ABT) is seeking permission to expand its facility in Kilkenny, Ireland. According to the report, Abbott hopes t...
January 16, 2026Homecaremag
MINNEAPOLIS-Medtronic Diabetes announced the expansion of United States pharmacy formulary access for its MiniMed 780G insulin pump, through agreements...
January 16, 2026Medical Design and Outsourcing
At Boston Scientific's new 400,000-square-foot Arbor Lakes campus near Minneapolis, the architecture is designed to get out of the researchers' way. By...
January 15, 2026Pulse2.0
Boston Scientific announced it has signed a definitive agreement to acquire Penumbra, Inc. in a cash-and-stock transaction valued at about $14.5 billio...
January 15, 2026Pharmabiz
Abbott announced a collaboration with AtaCor Medical to advance a next─generation investigational extravascular implantable cardioverter defibrillator ...
January 15, 2026PR Newswire
MILWAUKEE, Jan. 15, 2026 /PRNewswire/ -- Ademi LLP is investigating Penumbra (NYSE: PEN) for possible breaches of fiduciary duty and other violations o...

Frequently Asked Questions about Art Stent

  1. Who are Art Stent's top competitors?

    Art Stent's top 3 competitors are Amaranth Medical, Neotherix, Kuros Biosciences AG.

  2. Who is similar to Art Stent?

    Amaranth Medical is the most similar to Art Stent. Neotherix and Kuros Biosciences AG are also similar to Art Stent.

  1. Are Art Stent and Amaranth Medical competitors?

    Yes, Amaranth Medical is one of Art Stent’s top competitors.